CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16
作者:  Peng, Xia;  Hou, Pengcong;  Chen, Yi;  Dai, Yang;  Ji, Yinchun
收藏  |  浏览/下载：6/0  |  提交时间：2020/07/01
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
收藏  |  浏览/下载：52/0  |  提交时间：2019/12/16
Multiple comparisons of three different sources of biomaterials in the application of tumor tissue engineering in vitro and in vivo 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 卷号: 130, 页码: 166-176
作者:  Li, Wenfang;  Hu, Xueyan;  Wang, Shuping;  Xing, Yan;  Wang, Hai
收藏  |  浏览/下载：68/0  |  提交时间：2019/06/14
Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychotics 期刊论文
ARCHIV DER PHARMAZIE, 2019, 卷号: 352, 期号: 4, 页码: 13
作者:  Xu, Mingshuo;  Guo, Shuang;  Yang, Feipu;  Wang, Yu;  Wu, Chunhui
收藏  |  浏览/下载：43/0  |  提交时间：2020/07/01
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430
作者:  Long, Fei;  He, Ye;  Fu, Haoyu;  Li, Yun;  Bao, Xubin
收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01
Fast and Robust Reconstruction Method for Fluorescence Molecular Tomography based on Deep Neural Network 会议论文
The Moscone Center, San Francisco, California, USA, 2019-02-02
作者:  Huang C(黄超);  Meng Hui
收藏  |  浏览/下载：53/0  |  提交时间：2019/04/29
Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 3, 页码: 1064-1075
作者:  Wang, Lei;  Yang, Changyong;  Xie, Chengying;  Jiang, Jiahua;  Gao, Mingzhao
收藏  |  浏览/下载：22/0  |  提交时间：2020/07/01
A Novel mTORC1/2 Inhibitor (MTI-31) Inhibits Tumor Growth, Epithelial-Mesenchymal Transition, Metastases, and Improves Antitumor Immunity in Preclinical Models of Lung Cancer 期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 12
作者:  Zhang, Yan;  Zhang, Qianwen;  Chen, Yaqing;  Qian, Jianchang;  Zhang, Xuesai
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Part I: Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS) for Study Design And Humane Modeling Endpoints. 期刊论文
Shock (Augusta, Ga.), 2019, 卷号: 51, 期号: 1, 页码: 10-22
作者:  Zingarelli, Basilia*;  Coopersmith, Craig M.;  Drechsler, Susanne;  Efron, Philip;  Marshall, John C.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03
The Evaluation of Animal Models in the Development of Anticancer Agents: From Preclinical to Clinical Tests 期刊论文
CURRENT CANCER DRUG TARGETS, 2019, 卷号: 19, 页码: 277-284
作者:  Wang, Jie;  Dong, Haiyan;  Liu, Jian;  Zheng, Ning;  Xie, Xiaodong
收藏  |  浏览/下载：11/0  |  提交时间：2019/11/21

©版权所有 ©2017 CSpace - Powered by CSpace